ArticleThe Journal of experimental medicine2021

JAML promotes CD8 and γδ T cell antitumor immunity and is a novel target for cancer immunotherapy.

Joseph M McGraw et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.